DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Mira | ko |
dc.contributor.author | Jung, Kwangsoo | ko |
dc.contributor.author | Kim, Seung-Hyun | ko |
dc.contributor.author | Kim, Il-Sun | ko |
dc.contributor.author | Kim, Miri | ko |
dc.contributor.author | Shin, Mikyung | ko |
dc.contributor.author | Lee, Haeshin | ko |
dc.contributor.author | Park, Kook In | ko |
dc.contributor.author | Jang, Jae-Hyung | ko |
dc.date.accessioned | 2019-06-17T05:10:11Z | - |
dc.date.available | 2019-06-17T05:10:11Z | - |
dc.date.created | 2019-06-12 | - |
dc.date.issued | 2019-05 | - |
dc.identifier.citation | GENE THERAPY, v.26, no.5, pp.135 - 150 | - |
dc.identifier.issn | 0969-7128 | - |
dc.identifier.uri | http://hdl.handle.net/10203/262614 | - |
dc.description.abstract | Gene therapy technologies are inevitably required to boost the therapeutic performance of cell therapies; thus, validating the efficacy of gene carriers specifically used for preparing cellular therapeutics is a prerequisite for evaluating the therapeutic capabilities of gene and cell combinatorial therapies. Herein, the efficacy of a recombinant adeno-associated virus derivative (rAAVr3.45) was examined to evaluate its potential as a gene carrier for genetically manipulating interleukin-10 (IL10)-secreting human neural stem cells (hNSCs) that can potentially treat ischemic injuries or neurological disorders. Safety issues that could arise during the virus preparation or viral infection were investigated; no replication-competent AAVs were detected in the final cell suspensions, transgene expression was mostly transient, and no severe interference on endogenous gene expression by viral infection occurred. IL10 secretion from hNSCs infected by rAAVr3.45 encoding IL10 did not alter the transcriptional profile of any gene by more than threefold, but the exogenously boosted IL10 was sufficient to provoke immunomodulatory effects in an ischemic brain injury animal model, thereby accelerating the recovery of neurological deficits and the reduction of brain infarction volume. This study presents evidence that rAAVr3.45 can be potentially used as a gene carrier to prepare stem cell therapeutics. | - |
dc.language | English | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.title | Safety and efficacy evaluations of an adeno-associated virus variant for preparing IL10-secreting human neural stem cell-based therapeutics | - |
dc.type | Article | - |
dc.identifier.wosid | 000468743500001 | - |
dc.identifier.scopusid | 2-s2.0-85060793951 | - |
dc.type.rims | ART | - |
dc.citation.volume | 26 | - |
dc.citation.issue | 5 | - |
dc.citation.beginningpage | 135 | - |
dc.citation.endingpage | 150 | - |
dc.citation.publicationname | GENE THERAPY | - |
dc.identifier.doi | 10.1038/s41434-019-0057-8 | - |
dc.contributor.localauthor | Lee, Haeshin | - |
dc.contributor.nonIdAuthor | Choi, Mira | - |
dc.contributor.nonIdAuthor | Jung, Kwangsoo | - |
dc.contributor.nonIdAuthor | Kim, Seung-Hyun | - |
dc.contributor.nonIdAuthor | Kim, Il-Sun | - |
dc.contributor.nonIdAuthor | Kim, Miri | - |
dc.contributor.nonIdAuthor | Park, Kook In | - |
dc.contributor.nonIdAuthor | Jang, Jae-Hyung | - |
dc.description.isOpenAccess | N | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordPlus | GENE-TRANSFER | - |
dc.subject.keywordPlus | HYPOXIA-ISCHEMIA | - |
dc.subject.keywordPlus | VIRAL VECTORS | - |
dc.subject.keywordPlus | HARBOR LOCUS | - |
dc.subject.keywordPlus | BRAIN-INJURY | - |
dc.subject.keywordPlus | OPEN-LABEL | - |
dc.subject.keywordPlus | AAV | - |
dc.subject.keywordPlus | TRANSPLANTATION | - |
dc.subject.keywordPlus | INTEGRATION | - |
dc.subject.keywordPlus | THERAPY | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.